Autopsy report · NCT01374568

Changes in Bone Turnover With Increased Incretin Hormone Exposure

“Study closed by sponsor. Funding ended.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 11 months after it had already started.
• Ran for about 5 years 2 months before it stopped.
• 6 participants enrolled.
• Results were posted on the registry 1 year 9 months after it ended.

Vital statistics

Status

Terminated

Phase

Phase 4

Sponsor

University of Alabama at Birmingham

Sponsor type

University, hospital or other

Conditions

Type 2 Diabetes Mellitus

Interventions

sitagliptin; Placebo

Participants

6

Sites

1

Countries

United States

Trials that died the same way

• Treosulfan-Based Versus Clofarabine-Based Conditioning Before Donor Hematopoietic Stem Cell Transplant for the Treatment of Myelodysplastic Syndromes or Acute Myeloid Leukemia
  “The study was closed due to the end of funding.” (91% match in meaning)
• Abuse Potential of Buprenorphine/Naloxone
  “Funding ended for the study” (89% match in meaning)
• Managing Chronic Tendon Pain by Metformin
  “The study funding has ended.” (86% match in meaning)
• Effectiveness and Tolerance of Fentanyl Citrate in Painful Pain Induced During Diagnostic or Therapeutic Examinations in Cancer Patients
  “Study was cancelled by Sponsor.” (84% match in meaning)
• Mechanisms of Interferon Gamma-primed Mesenchymal Stromal Cells (MSCs) for Moderate-to-severe Persistent Asthma
  “The study terminated due to funding ending.” (84% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.